These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23907508)

  • 1. Medical costs of CKD in the Medicare population.
    Honeycutt AA; Segel JE; Zhuo X; Hoerger TJ; Imai K; Williams D
    J Am Soc Nephrol; 2013 Sep; 24(9):1478-83. PubMed ID: 23907508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying chronic kidney disease stage 3 with excess disease burden.
    Campbell A; Chu L; Crittenden S; Sutton A; Boehler A
    Am J Manag Care; 2024 Jun; 30(6):e172-e177. PubMed ID: 38912931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-cause costs increase exponentially with increased chronic kidney disease stage.
    Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
    Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
    Vupputuri S; Kimes TM; Calloway MO; Christian JB; Bruhn D; Martin AA; Nichols GA
    J Diabetes Complications; 2014; 28(1):10-6. PubMed ID: 24211091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden and Cost of Caring for US Veterans With CKD: Initial Findings From the VA Renal Information System (VA-REINS).
    Saran R; Pearson A; Tilea A; Shahinian V; Bragg-Gresham J; Heung M; Hutton DW; Steffick D; Zheng K; Morgenstern H; Gillespie BW; Leichtman A; Young E; O'Hare AM; Fischer M; Hotchkiss J; Siew E; Hynes D; Fried L; Balkovetz D; Sovern K; Liu CF; Crowley S; ;
    Am J Kidney Dis; 2021 Mar; 77(3):397-405. PubMed ID: 32890592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost to government and society of chronic kidney disease stage 1-5: a national cohort study.
    Wyld ML; Lee CM; Zhuo X; White S; Shaw JE; Morton RL; Colagiuri S; Chadban SJ
    Intern Med J; 2015 Jul; 45(7):741-7. PubMed ID: 25944415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative.
    Hoerger TJ; Simpson SA; Yarnoff BO; Pavkov ME; Ríos Burrows N; Saydah SH; Williams DE; Zhuo X
    Am J Kidney Dis; 2015 Mar; 65(3):403-11. PubMed ID: 25468386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inside ANEMIA of CKD: Projecting the Future Burden of Anemia of Chronic Kidney Disease and Benefits of Proactive Management: A Microsimulation Model of the Chinese Population.
    Retat L; Xiao D; Webber L; Martin A; Card-Gowers J; Yao J; Zhang Y; Zhang C; Garcia Sanchez JJ; Cabrera C; Grandy S; Rao N; Wu Y; Li Z; Xuan J
    Adv Ther; 2024 Oct; 41(10):3905-3921. PubMed ID: 39162981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme.
    Jha V; Al-Ghamdi SMG; Li G; Wu MS; Stafylas P; Retat L; Card-Gowers J; Barone S; Cabrera C; Garcia Sanchez JJ
    Adv Ther; 2023 Oct; 40(10):4405-4420. PubMed ID: 37493856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.
    Lin E; Chertow GM; Yan B; Malcolm E; Goldhaber-Fiebert JD
    PLoS Med; 2018 Mar; 15(3):e1002532. PubMed ID: 29584720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3-4 CKD.
    Kalantar-Zadeh K; Hollenbeak CS; Arguello R; Snyder S; Ashfaq A
    J Med Econ; 2020 Mar; 23(3):308-315. PubMed ID: 31726882
    [No Abstract]   [Full Text] [Related]  

  • 14. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and healthcare use of patients with chronic kidney disease in the Northern Territory, Australia.
    Chen W; Howard K; Gorham G; Abeyaratne A; Zhao Y; Adegboye O; Kangaharan N; Talukder MRR; Taylor S; Cass A;
    BMC Health Serv Res; 2024 Jul; 24(1):791. PubMed ID: 38982437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease.
    Herzog CA; Natwick T; Li S; Charytan DM
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1420-1426. PubMed ID: 29909107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical costs associated with chronic kidney disease progression in an Asian population with type 2 diabetes mellitus.
    Low S; Lim SC; Zhang X; Wang J; Yeo SJD; Yeoh LY; Liu YL; Subramaniam T; Sum CF
    Nephrology (Carlton); 2019 May; 24(5):534-541. PubMed ID: 30141833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage.
    Gagnon-Sanschagrin P; Liang Y; Sanon M; Oberdhan D; Guérin A; Cloutier M
    J Med Econ; 2021; 24(1):193-201. PubMed ID: 33464936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011.
    Ozieh MN; Dismuke CE; Lynch CP; Egede LE
    Diabetes Res Clin Pract; 2015 Jul; 109(1):185-90. PubMed ID: 25935258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The social cost of chronic kidney disease in Italy.
    Turchetti G; Bellelli S; Amato M; Bianchi S; Conti P; Cupisti A; Panichi V; Rosati A; Pizzarelli F;
    Eur J Health Econ; 2017 Sep; 18(7):847-858. PubMed ID: 27699568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.